1. Home
  2. RPC vs BBNX Comparison

RPC vs BBNX Comparison

Compare RPC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ridgepost Capital Inc. Class A Common Stock

RPC

Ridgepost Capital Inc. Class A Common Stock

N/A

Current Price

$9.68

Market Cap

869.8M

Sector

Finance

ML Signal

N/A

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

N/A

Current Price

$16.84

Market Cap

997.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RPC
BBNX
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
869.8M
997.9M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
RPC
BBNX
Price
$9.68
$16.84
Analyst Decision
Buy
Buy
Analyst Count
4
15
Target Price
$13.00
★ $25.10
AVG Volume (30 Days)
531.4K
★ 1.1M
Earning Date
11-04-2026
10-27-2026
Dividend Yield
★ 1.63%
N/A
EPS Growth
6.25
★ 78.95
EPS
★ 0.23
N/A
Revenue
★ $297,346,000.00
$100,251,000.00
Revenue This Year
$19.99
$25.22
Revenue Next Year
$19.85
$47.09
P/E Ratio
$42.52
★ N/A
Revenue Growth
0.30
★ 53.94
52 Week Low
$6.79
$8.80
52 Week High
$10.08
$32.71

Technical Indicators

Market Signals
Indicator
RPC
BBNX
Relative Strength Index (RSI) 66.43 47.25
Support Level $7.29 $15.92
Resistance Level N/A $18.20
Average True Range (ATR) 0.40 1.65
MACD 0.04 0.03
Stochastic Oscillator 75.32 32.09

Price Performance

Historical Comparison
RPC
BBNX

About RPC Ridgepost Capital Inc. Class A Common Stock

Ridgepost Capital Inc, formelrly P10 Inc is a player in the alternative asset management sector, specializing in multi-asset class private market solutions. It offers a range of investment solutions, including specialized funds, separate accounts, secondary investments, direct investments, and co-investments across various asset classes and geographies. These solutions cater to diverse investor needs within the private markets, aiming to deliver superior risk-adjusted returns. With a focus on middle and lower-middle markets, the company's portfolio includes Private Equity, Venture Capital, Impact Investing, and Private Credit. Its Revenue mainly comes from recurring management and advisory fees earned on committed capital, typically locked up for ten to fifteen years.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: